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Introduction
The distribution of risk factors for stroke shows age dependence. Cardiogenic etiology is present in 20% of young people with stroke [1] . The share of heart disease in causing cerebral ischemia, however, may be more serious due to the fact that in approximately 20-30% of patients it is impossible to clearly determine its cause [1, 2] . The diagnosis of cardio-embolic stroke relates to patients with embolic stroke of the cerebral or cerebellar cortex, and specific heart disease with no other causes of stroke [3] . The risk of cerebral embolism varies according to the pathology of the heart. In 1997 Welch et al. presented the classification of the causes of cardiogenic strokes by making their division associated with absolute and relative risk of stroke occurrence [4] . The causes of absolute risk of cerebral embolism according to the division are: atrial fibrillation, mitral stenosis, mechanical heart valves, early myocardial infarction, infective endocarditis, atrial myxoma and the presence of thrombus in the left ventricle without the coexistence of the above-mentioned abnormalities. The relative risk factors of cardiogenic cerebral embolism according to the Welch et al. classification include mitral valve prolapse, patent foramen ovale (PFO), atrial septal aneurysm and segmental left ventricular dysfunction. The degree of risk of cardiogenic stroke occurrence in these latter cases is the subject of controversy. Participation of cardio-embolism in the pathogenesis of stroke and the incidence of cryptogenic strokes in young people are shown in the table (Table 1) with inclusion of the most recent findings [1, 2, 5, 6] . The incidence of cardio-embolic strokes is similar in the group of young and old people, but its pathogenesis is different.
Clinical situations associated with potential risk of cardio-embolic stroke in the young are presented below. For the purposes of this study an age below 55 years was considered as a "young age," which is consistent with the criterion adopted in most studies referred to by the authors.
Patent foramen ovale
Prevalence of PFO in patients over 45 years of age is about 24% [7] . The incidence and the size of leakage due to its presence decrease with age [8] . The importance of the presence of PFO for the occurrence of stroke remains undetermined. It was found that young patients with stroke have significantly higher incidence of PFO in comparison to healthy subjects [9, 10] . It was also found that patients with stroke and persistent foramen ovale were younger and had a lower number of traditional risk factors for cerebral vascular disease in comparison to patients with stroke but without the presence of PFO [11] . There is no doubt about the statistical relationship between coexistence of PFO and stroke; however, this does not mean a cause and effect relationship. Given the prevalence of PFO based for example on the results of echocardiography, it seems likely that coexistence of PFO and stroke is coincidental, as the presence of PFO in the group of all patients suffering from stroke is estimated at around 30% [12] . There is disagreement among authors on the importance of the relationship between the size of the leak and the number of emboli for cerebral ischemia and whether the size of the PFO is important for recurrence of stroke [11, 13] . Results of the multicenter CODICIA study involving a Spanish population did not confirm this relationship [14] . The presence of PFO is a factor facilitating the achievement of cerebral circulation by paradoxical emboli, which is hemodynamically justified, but in practice in the overwhelming majority of patients with PFO and stroke the origin of emboli cannot be determined. Emboli may be derived from the pelvic veins. It is also likely that the mechanism of paradoxical embolism is not the main one, which points towards other pathomechanisms of brain perfusion abnormalities associated with the presence of PFO such as blood clot formation in the septal wall or within the PFO, which may be suggested by fibrin deposits found during cardiac surgery. There is a theory suggesting increased susceptibility of the atria to cardiac arrhythmias, including clinically silent ones, caused by stretching of atrial walls by patent foramen ovale or atrial septal aneurysm [15] . In fact, it is not the presence of patent foramen ovale but the other pathologies "induced" by its presence that could be the cause of cerebrovascular disease [15] [16] [17] [18] . Another issue is the coexistence of PFO and coagulation disorders in young patients with stroke. A cumulative effect of factor V Leiden or prothrombin gene (G20210A) mutations and the presence of PFO for the occurrence of cerebral circulation disorders is emphasized. In the studies of Botto et al. and Pezzini et al. these mutations occurred significantly more often in patients with stroke and PFO as compared to healthy individuals [19, 20] . Coagulation disorders in young patients with stroke are of minor importance, which however increases with the presence of other pathologies, such as PFO.
Patent foramen ovale with concomitant atrial septal aneurysm, migraine or coagulation disorders is an example of interaction of risk factors having a small or doubtful potential action if present in isolation. According to the TOAST system of classification of risk factors of stroke, patent foramen ovale was categorized as medium-risk pathology of cerebral embolism [21] . In the more recent A-S-C-O system it was placed among the causes of cardioembolism of uncertain significance for the cerebral circulation [22] .
Analysis of risk factors for cryptogenic stroke in young patients in the Helsinki Young Stroke Registry has not demonstrated the relevance of the presence of PFO. It is worth noting, however, that the incidence of this atrial septal abnormality in a group of more than 1,000 patients was lower than in the population, which is explained by the authors by insufficient number of properly performed transesophageal echocardiographic examinations [1] .
In patients with ischemic stroke or transient ischemic attack who have patent foramen ovale it is reasonable to start antiplatelet therapy (class IIa, level B). There are insufficient data to determine the importance of anticoagulant therapy (IIb, B) or surgical intervention (IIb, C) [23] . Ongoing randomized studies compare surgical correction and conservative treatment of PFO in young patients after stroke. The preliminary results of the CLOSURE 1 study have not confirmed a significant advantage of intervention over conservative treatment.
Atrial septal aneurysm
Another anomaly of the interatrial septum is aneurysm (ASA), which often co-exists with PFO, and is considered as a potential risk factor for the occurrence of first and recurrent stroke [9, 10, [24] [25] [26] . Aneurysms often coexist with larger leaks and increase the tendency for thrombus formation, which could explain the recurrent nature of symptomatic cerebral embolism. The presence of ASA was found in 2% of the young adults with the first stroke from the Helsinki Young Stroke Registry and coexistence of the aneurysm and PFO was confirmed in 7% of these patients [1] . In the prospective FOP/ASA study the annual risk of recurrent stroke in patients under 55 years of age with PFO and ASA was 4% and with PFO only 0.6% [27] . The results of the PICSS study do not confirm the signifi- T Ta ab bl le e 1 1. . Frequency of cardioembolic stroke in young people cant relation of these pathologies of the interatrial septum with an increased risk of a recurrent stroke [28] . The cited studies differed in terms of qualification rules and endpoints. It is worth noting that ASA accompanied by migraine was diagnosed in 34.4% of patients with stroke < 55 years of (while migraine without ASA in the presented material occurred in 18.5% of cases) [11] . It is likely that there is reinforcement between factors of potential embolic and hemodynamic significance for cerebral circulation. Most authors classify ASA in the group of low or uncertain risk factors of stroke.
Atrial fibrillation
Atrial fibrillation (AF) is responsible for a 5-fold increase of the risk of stroke and thus it is a major cause of cerebral embolism. According to the studies on different ethnic populations, the incidence of atrial fibrillation increases with age and predominates in men in any age range. The incidence of atrial fibrillation in people up to 60 years of age is estimated to be 0.1-0.2%, while in patients older than 80 years it is 9.1-11% [29] [30] [31] . The association of stroke with atrial fibrillation is found in 4% of young patients with stroke. Atrial fibrillation was found as a risk factor in 4.2% of patients below 49 years of age with the first stroke [1] . In about 1/5 of the cases AF coexisted with structural heart abnormalities, involving mainly the interatrial septum. It is believed that all types of AF (paroxysmal, persistent or permanent) are associated with similar risk of stroke [32] . It is worth mentioning about the so-called clinically silent cerebral infarctions in the course of atrial fibrillation found in neuroimaging studies and which can cause cognitive dysfunction [33] .
The prevention of stroke in patients with atrial fibrillation should include anticoagulation (class I, level A). Antiplatelet therapy is recommended for patients who are unable to use oral anticoagulants (class I, level A) [23] . Closure of the left atrial appendage in patients with atrial fibrillation and recurrent cerebral accidents in spite of antithrombotic therapy can be a therapeutic option reducing the risk of stroke and its severe complications. The importance of occlusive methods for the secondary prevention of stroke is currently undetermined.
Infective endocarditis
Stroke as a consequence of embolism with vegetations is a major neurological complication of this heart disease and occurs in 9-23% of patients [34, 35] . Infective endocarditis constituted 3% of causes of cardio-embolic stroke in young people in the Helsinki Stroke Registry [1] . Both cerebral infarction and transient ischemic attack are associated with worse prognosis. In the study of Anderson et al. 42% of patients with infective endocarditis (IE) complicated by stroke died within a year of illness. Patients with stroke require anticoagulation except for hemorrhagic stroke, which is the reason for deferral of such therapy.
The presence of neurological complications is not a contraindication for cardiac surgery. Infective endocarditis is a condition excluding the use of intravenous thrombolytic therapy of stroke.
Other causes of cardio-embolic strokes in the young
Other causes of cardiogenic stroke in young patients include dilated cardiomyopathy, valvular heart disease, acute myocardial infarction, hypo-or akinesis of the left ventricular wall, atrial myxoma and endocardial fibrosis in the course of hypereosinophilia [1, 36] . A cerebral incident may be the first clinical manifestation of thrombo-embolic complications of these diseases.
Summary
Although the nature and the impact of the risk factors of stroke vary across decades of age, cardiogenic embolism invariably plays an important role. A high percentage of strokes in young patients is attributed to PFO, while cardiac arrhythmias are becoming more important in people over 60 years of age. In a substantial proportion of young patients with stroke despite extensive diagnostics it is impossible to clearly identify the etiological factor or the risk of its relapse. In many cases, the cause of stroke is assumed to be a low risk pathology in which the management has not been specified. Results of the ongoing trials comparing conservative and occlusive treatment in patients with pathologies of the interatrial septum will help to develop optimal strategies for the prevention and treatment of stroke in this particular group of patients.
